TP53 and acute lymphoblastic leukemia: In contrast, none of the B‐ALL/LBL cases showed these mutational features but displayed TP53, KRAS, and PAX5 mutations that are frequently seen in B‐ALL/LBL [14, 15, 16] (Figure 3A).